POSTER SESSION IV
Tuesday, March 4, 2008 — 1:00 PM - 4:30 PM
Convention Center Exhibit Hall A
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
QUALITY ASSURANCE
Poster#
Title and Authors
Itinerary Planner
174
Monitoring Critical Values in Medical Kidney Diseases: A Step Towards Quality of Care
(1621)
A Kalra, FG Nunes, EC Huang, HG Rennke, V Nosé - Brigham and Women's Hospital, Boston, MA
Critical Values in Surgical Pathology: Continuous Monitoring To Improve Patient Safety
(1620)
EC Huang, V Nosé - Brigham and Women's Hospital, Harvard Medical School, Boston, MA
The Benefits of Hospital-Wide Electronic Safety Reporting Systems in Developing Pathology-Based Quality Improvement Projects
(1631)
MD Post, L Listro, D MacMillan, D Misiano, AE Rosenberg - Massachusetts General Hospital, Boston, MA
Process Improvement in the Histology Laboratory Using a Collaborative Problem Resolution Tool
(1615)
AE Bennett, L McDonald, DE Priganc, G GOSS, JL Hunt - Cleveland Clinic, Cleveland, OH; Orion Advisory, Charlotte, NC
Just-in-Time Surgical Pathology Specimen Workflow with Comprehensive Barcode Tracking and Lean/Six Sigma Software Design as a Prototypic Next Generation Laboratory Information System for Comprehensive Error Reduction
(1643)
L Yu, MS Almiski, UJ Balis - University of Michigan Health System, Ann Arbor, MI; Wayne State University Medical School, Detroit, MI
Process Improvement of Surgical Pathology Turnaround Time: A Departmental Effort at a Regional Veterans Affairs Medical Center
(1614)
S Askari, DR Sorenson, SL Ewing, R Skeate - VAMC, Minneapolis; U of Minnesota, Minneapolis
Lean Process Improvement Shortens Total Molecular Diagnostic Testing Time
(1617)
M Cankovic, L Whiteley, R Brown, R D'Angelo, RJ Zarbo - Henry Ford Hospital, Detroit, MI
Using a Business Review and Scorecard To Manage the Business of Surgical Pathology
(1642)
LM Yerian, DE Priganc, AE Bennett, G Goss, JL Hunt - Cleveland Clinic, Cleveland, OH; Orion Advisory, LLC, Charlotte, NC
Analysis of a Standardized Pathology Reporting Process Based on the College of American Pathology Checklists
(1629)
AV Parwani, M Srinivasan, S Winters - University of Pittsburgh Medical Center, Pittsburgh, PA; Univeristy of Pittsburgh Cancer Institute, Pittsburgh, PA
Lean Redesign of Digital X-Ray of Breast Biopsies for Calcifications - Reduction of Turn around Time and Wasteful Recuts in the Henry Ford Production System
(1625)
A Niemeier, R D'Angelo, A Ormsby, U Raju, RJ Zarbo - Henry Ford Health System, Detroit, MI
Best Practices in Breast Pathology: Practical Quality Assurance/Patient Safety Program in a Womens Hospital. A Descriptive Study
(1619)
DJ Dabbs, GJ Carter, MW Jones, R Bhargava - Magee-Womens Hospital, Pittsburgh, PA
High Concordance between Local and Central Laboratory Testing of Biomarkers in the Capcetabine + Docetaxel +/-Trastuzumab Neoadjuvant Breast Cancer Clinical Trial
(1635)
MS Ross, E Slodkowska, CE Sheehan, AB Boguniewicz, S Gluck, M Royce, C Moisa, JS Ross - Albany Medical Center, Albany, NY; University of Miami Miller School of Medicine, Miami, FL; University of New Mexico, Albuquerque, NM; Roche Laboratories, Inc, Nutley, NJ
The Significance of Intraoperative Gross Examination of Margins on Patient's Management: A Breast Model
(1630)
A Plotkin, J Zubovits, C Holloway, S Nofech-Mozes - Sunnybrook Health Sciences Centre, University of Toronto, Canada
Intraoperative Consultation for Axillary Sentinel Lymph Node Biopsy: An 8-Year Audit
(1626)
S Nofech-Mozes, W Hanna, T Cil, ML Quan, C Holloway, MA Khalifa - Sunnybrook Health Sciences Centre, University of Toronto, Canada
Low Lymph Node Count after Neoadjuvant Chemotherapy for Breast Cancer Should Not Be Assumed To Represent Complete Axillary Dissection
(1636)
S Sahoo, AB Chagpar - University of Louisville, Louisville, KY
Interobserver Variability in the Diagnosis of Extranodal Extension of Malignancy
(1634)
S Raphael, C Rowsell, C Macmillan, C Streutker, I Weinreb - University of Toronto, Toronto, ON, Canada
Effect of Double Viewing Needle Core Prostate Biopsy Tissues on Error Reduction
(1632)
SS Raab, KR Geisinger, EM Wojcik, AV Parwani, C Jensen, CM Vrbin, DM Grzybicki - University of Pittsburgh, Pittsburgh, PA; Wake Forest University, Winston-Salem, NC; Loyola University, Maywood, IL; University of Iowa, Iowa City, IA
Comparison of Thinprep and Conventional Smear Preparations in the Diagnosis of Thyroid Nodules by Fine Needle Aspiration Biopsy: A 10-Year Experience
(1640)
X Wang, Y Liu, M Prasad, A Fischer, A Khan - University of Massachusetts Medical School, Worcester, MA
Comparison of ZAP-70 Expression and Cytogenetic Risks in CLL Patients: A New Practical Insight for Their Molecular Risk Stratification
(1612)
S Alexanian, F Chaves, NP Rao, S Song - UCLA, Los Angeles, CA
Utility of Molecular Fixative UMFIX in Preservation of Morphology and Nucleic Acid Integrity in Paraffin Embedded Surgical Specimens
(1616)
M Cankovic, J Beher, R Robinette, L Whiteley, RJ Zarbo - Henry Ford Hospital, Detroit, MI
Distinctive Morphometric Signatures Exist within Nuclei of Gleason Pattern 4 Areas in Gleason 7 Prostate Cancer with Differing Primary Grades on Needle Biopsy
(1638)
G Venkataraman, K Rycyna, V Ananthanarayanan, KA Hutchens, GP Paner, RC Flanigan, EM Wojcik - Loyola University Medical Center, Maywood, IL; Stritch School of Medicine, Loyola University Medical Center, Maywood, IL; University of Illinois, Chicago, IL
Is a Negative Immunohistochemical Control (No Primary Antibody) Routinely Needed?
(1613)
FA Alghamdi, CB Gilks, AM Gown, M Hayes, J Cupples - Vancouver General Hospital, Vancouver, BC, Canada; PhenoPath Laboratories, Seattle, WA; British Columbia Cancer Agency, Vancouver, BC, Canada; Royal Colombian Hospital, Westminster, BC, Canada
button next to any title to add to Itinerary Planner...
Add
